Mutational profiles reveal an aberrant TGF-β-CEA regulated pathway in colon adenomas

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Chen, Jian ^a   Raju, Gottumukkala S ^a   Jogunoori, Wilma ^b   Menon, Vipin ^a   Majumdar, Avijit ^a   Chen, Jiun Sheng ^a   Gi, Young Jin ^a   Jeong, Yun Seong ^a   Phan, Liem ^a   Belkin, Mitchell ^b   Gu, Shoujun ^c   Kundra, Suchin ^a   Mistry, Nipun A ^a   Zhang, Jianping ^a   Su, Xiaoping ^a   Li, Shulin ^a   Lin, Sue Hwa ^a   Javle, Milind ^a   McMurray, John S ^a   Rahlfs, Thomas F ^a   Mishra, Bibhuti ^b   White, Jon ^b   Rashid, Asif ^a   Beauchemin, Nicole ^d   Weston, Brian R ^a   Shafi, Mehnaz A ^a   Stroehlein, John R ^a   Davila, Marta ^a   Akbani, Rehan ^a   Weinstein, John N ^a   Wu, Xifeng ^a   Mishra, Lopa ^a,b,c   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TUMOR MARKER;

AMINO ACID SUBSTITUTION; ANTIBODY LABELING; ARTICLE; CANCER GROWTH; CANCER RISK; CEA GENE; COLON ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; TGF BETA GENE; TGF BETAR1 GENE; TGF BETAR2 GENE; TUMOR VOLUME; ADENOMA; APOPTOSIS; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; COLON; COLON TUMOR; COMPARATIVE STUDY; DISEASE COURSE; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETICS; HIGH THROUGHPUT SEQUENCING; IMMUNOPRECIPITATION; METABOLISM; MUTATION; PATHOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADENOMA; APOPTOSIS; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CARCINOEMBRYONIC ANTIGEN; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COLON; COLONIC NEOPLASMS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; MUTATION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84964669930     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0153933     Document Type: Article

References (39)

1. International Agency for Research on Cancer: World Health Organization. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 Lyon, France: International Agency for Research on Cancer: World Health Organization; 2014 [cited 2014 March 27]. Available from: http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx.
2. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011; 61(4):212-36. doi: 10.3322/caac.20121 PMID: 21685461
3. Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. The New England journal of medicine. 2012; 366(8):687-96. doi: 10.1056/NEJMoa1100370 PMID: 22356322
4. Shaukat A, Mongin SJ, Geisser MS, Lederle FA, Bond JH, Mandel JS, et al. Long-term mortality after screening for colorectal cancer. The New England journal of medicine. 2013; 369(12):1106-14. doi: 10.1056/NEJMoa1300720 PMID: 24047060
5. Loberg M, Kalager M, Holme O, Hoff G, Adami HO, Bretthauer M. Long-term colorectal-cancer mortality after adenoma removal. The New England journal of medicine. 2014; 371(9):799-807. doi: 10.1056/NEJMoa1315870 PMID: 25162886
6. Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. The New England journal of medicine. 2006; 355 (24):2533-41. PMID: 17167136
7. O'Brien MJ, Winawer SJ, Zauber AG, Gottlieb LS, Sternberg SS, Diaz B, et al. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology. 1990; 98(2):371-9. PMID: 2403953
8. Tomasetti C, Vogelstein B. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science. 2015; 347(6217):78-81. doi: 10.1126/science.1260825 PMID: 25554788
9. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990; 61(5):759-67. PMID: 2188735
10. Garraway LA, Lander ES. Lessons from the cancer genome. Cell. 2013; 153(1):17-37. doi: 10.1016/j. cell.2013.03.002 PMID: 23540688
11. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature. 2009; 458(7239):719-24. doi: 10.1038/nature07943 PMID: 19360079
12. Cancer Genome Atlas N. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012; 487(7407):330-7. doi: 10.1038/nature11252 PMID: 22810696
13. De Sousa EMF, Wang X, Jansen M, Fessler E, Trinh A, de Rooij LP, et al. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nature medicine. 2013; 19(5):614-8. doi: 10.1038/nm.3174 PMID: 23584090
14. Sadanandam A, Lyssiotis CA, Homicsko K, Collisson EA, Gibb WJ, Wullschleger S, et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nature medicine. 2013; 19(5):619-25. doi: 10.1038/nm.3175 PMID: 23584089
15. Delker DA, McGettigan BM, Kanth P, Pop S, Neklason DW, Bronner MP, et al. RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers. PloS one. 2014; 9(2):e88367. doi: 10.1371/journal.pone.0088367 PMID: 24533081
16. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, et al. The genomic landscapes of human breast and colorectal cancers. Science. 2007; 318(5853):1108-13. PMID: 17932254
17. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, et al. Signatures of mutational processes in human cancer. Nature. 2013; 500(7463):415-21. doi: 10.1038/nature12477 PMID: 23945592
18. Paz-Yaacov N, Bazak L, Buchumenski I, Porath HT, Danan-Gotthold M, Knisbacher BA, et al. Elevated RNA Editing Activity Is a Major Contributor to Transcriptomic Diversity in Tumors. Cell Rep. 2015; 13 (2):267-76. doi: 10.1016/j.celrep.2015.08.080 PMID: 26440895
19. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010; 138 (6):2073-87 e3. doi: 10.1053/j.gastro.2009.12.064 PMID: 20420947
20. Kreso A, van Galen P, Pedley NM, Lima-Fernandes E, Frelin C, Davis T, et al. Self-renewal as a therapeutic target in human colorectal cancer. Nature medicine. 2014; 20(1):29-36. doi: 10.1038/nm.3418 PMID: 24292392
21. Beauchemin N, Benchimol S, Cournoyer D, Fuks A, Stanners CP. Isolation and characterization of fulllength functional cDNA clones for human carcinoembryonic antigen. Mol Cell Biol. 1987; 7(9):3221-30. PMID: 3670312
22. Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell. 1989; 57(2):327-34. PMID: 2702691
23. Beauchemin N, Arabzadeh A. Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis. Cancer metastasis reviews. 2013; 32(3-4):643-71. doi: 10.1007/s10555-013-9444-6 PMID: 23903773
24. Li Y, Cao H, Jiao Z, Pakala SB, Sirigiri DN, Li W, et al. Carcinoembryonic antigen interacts with TGF-β receptor and inhibits TGF-β signaling in colorectal cancers. Cancer Res. 2010; 70(20):8159-68. doi: 10.1158/0008-5472.CAN-10-1073 PMID: 20889724
25. Samara RN, Laguinge LM, Jessup JM. Carcinoembryonic antigen inhibits anoikis in colorectal carcinoma cells by interfering with TRAIL-R2 (DR5) signaling. Cancer Res. 2007; 67(10):4774-82. PMID: 17510406
26. Liao X, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M, et al. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. The New England journal of medicine. 2012; 367 (17):1596-606. doi: 10.1056/NEJMoa1207756 PMID: 23094721
27. Massague J, Blain SW, Lo RS. TGF-β signaling in growth control, cancer, and heritable disorders. Cell. 2000; 103(2):295-309. PMID: 11057902
28. Majumdar A, Curley SA, Wu X, Brown P, Hwang JP, Shetty K, et al. Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2012; 9(9):530-8. doi: 10.1038/nrgastro.2012.114 PMID: 22710573
29. Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L, et al. TGF-β: duality of function between tumor prevention and carcinogenesis. J Natl Cancer Inst. 2014; 106(2):djt369.
30. Tang Y, Katuri V, Srinivasan R, Fogt F, Redman R, Anand G, et al. Transforming growth factor-β suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis. Cancer Res. 2005; 65(10):4228-37. PMID: 15899814
31. Mishra L, Shetty K, Tang Y, Stuart A, Byers SW. The role of TGF-β and Wnt signaling in gastrointestinal stem cells and cancer. Oncogene. 2005; 24(37):5775-89. PMID: 16123810
32. Yashiro M, Hirakawa K, Boland CR. Mutations in TGF-β-RII and BAX mediate tumor progression in the later stages of colorectal cancer with microsatellite instability. BMC Cancer. 2010; 10:303. doi: 10.1186/1471-2407-10-303 PMID: 20565851
33. Beauchemin N, Arabzadeh A. Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis. Cancer Metastasis Rev. 2013.
34. Roda G, Jianyu X, Park MS, DeMarte L, Hovhannisyan Z, Couri R, et al. Characterizing CEACAM5 interaction with CD8alpha and CD1d in intestinal homeostasis. Mucosal Immunol. 2014; 7(3):615-24. doi: 10.1038/mi.2013.80 PMID: 24104458
35. Chen L, Chen Z, Baker K, Halvorsen EM, da Cunha AP, Flak MB, et al. The short isoform of the CEACAM1 receptor in intestinal T cells regulates mucosal immunity and homeostasis via Tfh cell induction. Immunity. 2012; 37(5):930-46. doi: 10.1016/j.immuni.2012.07.016 PMID: 23123061
36. Muturi HT, Dreesen JD, Nilewski E, Jastrow H, Giebel B, Ergun S, et al. Tumor and endothelial cellderived microvesicles carry distinct CEACAMs and influence T-cell behavior. PloS one. 2013; 8(9): e74654. doi: 10.1371/journal.pone.0074654 PMID: 24040308
37. Muenzner P, Rohde M, Kneitz S, Hauck CR. CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells. J Cell Biol. 2005; 170 (5):825-36. PMID: 16115956
38. Kuespert K, Pils S, Hauck CR. CEACAMs: their role in physiology and pathophysiology. Curr Opin Cell Biol. 2006; 18(5):565-71. PMID: 16919437
39. Tiernan JP, Perry SL, Verghese ET, West NP, Yeluri S, Jayne DG, et al. Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting. Br J Cancer. 2013; 108(3):662-7. doi: 10.1038/bjc.2012.605 PMID: 23322207